Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment

The significant growth in type 2 diabetes mellitus (T2DM) prevalence strikes a common threat to the healthcare and economic systems globally. Despite the availability of several anti-hyperglycaemic agents in the market, none can offer T2DM remission. These agents include the prominent incretin-based...

Full description

Bibliographic Details

Published in:	Pharmacological Research
Main Authors:	Kok-Hou Lok, Nicholas J. Wareham, Rajesh Sreedharan Nair, Chee Wun How, Lay-Hong Chuah
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Subjects:	Bariatric surgery Enteroendocrine L-cell Incretin Pharmaceutical formulation Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S1043661822001827